was the most active stock on the Instinet platform in the extended session, as investors sent the shares of the energy merchant fractionally higher on rumors that
might be considering an investment in the company, or possibly even a merger.
Enron, whose stock has plunged during the last three weeks as shareholders fretted about the company's relationships with a series of investment partnerships -- which have led to a
Securities and Exchange Commission
probe -- ticked up 0.1% to $9.06.
was also active after the bell, losing 2.5% to $1.59.
was tacking on 0.5% to $28.44, and the
Nasdaq 100 Tracking Stock
was unchanged at $38.15.
was one of the extra session's biggest losers, falling 3.8% to $24.51 after saying October same-store sales fell 4.4% from the same month a year ago. The company also indicated that earnings for the third and fourth quarters could come in a little short of analysts' estimates.
was up 0.3% to $18.99,
was gaining 0.2% to $12.61, and
was flat at $15.58.
rose 2% to $55.32 after hours. Earlier in the day, the company laid out its drug development plans for the next few years. The stock lost 2.7% in regular trading.
was losing 8.3% to $47.75 after the close, and
was climbing 2% to $37.02.